Skip to main content
. 2005 May;54(5):691–697. doi: 10.1136/gut.2004.042796

Table 2.

 Risk factors for splanchnic vein thrombosis: results of univariate analysis

Splanchnic vein thrombosis p Value
Yes (n = 38) No (n = 213)
Age (y) 49.2 (6.9) 49.5 (8.8) 0.86
Sex (M/F) 28/10 168/45 0.52
Indication for transplantation 9 (23.7%) 50 (23.5 %) 0.72
    Alcohol related cirrhosis 6 (15.8 %) 16 (7.5 %)
    HBV related cirrhosis 6 (15.8 %) 36 (16.9 %)
    HCV related cirrhosis 11 (28.9 %) 73 (34.3 %)
    HCC 2 (5.3 %) 20 (9.4%)
    Biliary (PBC and PSC) 4 (10.5 %) 18 (8.5 %)
    Other
Prothrombin time (% of normal) 52.6 (17.8) 58.7 (20.6) 0.08
Factor V (% of normal) 54.5 (21.2) 62.1 (25.7) 0.09
Bilirubin (μmol/l) 54.6 (79.4) 68.1 (71.6) 0.29
Albumin (g/l) 33 (5.5) 34.8 (7.9) 0.20
Creatinine (μmol/l) 77.7 (19.5) 88 (83.8) 0.45
Platelets count (109/l) 77.4 (36.3) 111.6 (69.2) 0.001
Episodes of encephalopathy 12/38 (31.6%) 49/213 (23%) 0.18
Chronic encephalopathy 2/38 (5.3%) 14/213 (6.6%) 0.30
Episodes of ascites 30/38 (78.9%) 126/213 (59.2%) 0.009
Refractory ascites 15/38 (39.5%) 55/213 (25.8%) 0.11
Spontaneous bacterial peritonitis 6/38 (15.8%) 33/213 (15.5%) 0.96
Child-Pugh score (A/B/C) 4/21/13 61/83/69 0.04
MELD score 12.7 (5) 11.5 (6.6) 0.80
Oesophageal varices 0.22
    None/grade1/grade 2/grade 3 5/9/18/6 51/42/101/19
Variceal bleeding 18/38 (47.4%) 48/165 (29.1) 0.001
Endoscopic treatment 0.07
    Sclerosis/ligation 8/4 20/13
    Abdominal surgery in the past 13/38 (34.2%) 56/213 (26.3%) 0.32

HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; PBC, primary biliary cirrhosis, PSC, primary sclerosing cholangitis.